Benign Prostatic Hyperplasia

• CLINICAL_TRIALS research · 2009-11-26
  Clinical Trial Update: Clinical Study to Assess the Influence of a Saw Palmetto Preparation in Patients With Benign Prostatic Hyperplasia (BPH) and Sexual Dysfunctions [Phase 4]

  A Phase 4 clinical study is evaluating whether a saw palmetto preparation influences sexual dysfunction in men with benign prostatic hyperpl…

• CLINICAL_TRIALS research · 2008-06-05
  Clinical Trial Update: A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart [Phase 4]

  This Phase 4 trial investigates whether switching from finasteride (Proscar) to dutasteride (Avodart) improves symptoms of benign prostatic …

• CLINICAL_TRIALS research · 2007-09-05
  Clinical Trial Update: Early Detection of Prostate Cancer by FACS

  A clinical trial update on using fluorescence-activated cell sorting (FACS) for early detection of prostate cancer; the current trial status…

• CLINICAL_TRIALS research · 2007-05-01
  Clinical Trial Update: Evaluation of the ProstaPlant Prostate Stent Insertion in Ex Vivo Human Prostate [Phase 1]

  Ex vivo evaluation of the ProstaPlant Prostate Stent for benign prostatic hyperplasia in human prostate tissue is described in this Phase 1 …

• CLINICAL_TRIALS research · 2007-04-18
  Clinical Trial Update: Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP) [NA]

  This is a clinical trial update evaluating dutasteride to improve perioperative and long-term outcomes after photoselective vaporization of …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2007-02-05
  Clinical Trial Update: Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma

  This clinical trial update discusses Annexin A3 as a protein-based biomarker for non-invasive molecular diagnostics of prostate carcinoma, r…